Everest Medicines raises $200M; Epirium Bio targets $55M Series Bnews2025-07-25T14:42:58+00:00July 25th, 2025|Endpoints News|
Updated: Bristol Myers snags Cristian Massacesi from AstraZeneca as its new chief medical officernews2025-07-25T14:39:55+00:00July 25th, 2025|Endpoints News|
Pharma companies slow down their manufacturing projects in Ireland, data shownews2025-07-25T14:29:24+00:00July 25th, 2025|Endpoints News|
Generate’s head of R&D returns to Merck; Galapagos shuffles leadership teamnews2025-07-25T11:00:19+00:00July 25th, 2025|Endpoints News|
CHMP recommends against Elevidys’ approval in Europenews2025-07-25T10:33:38+00:00July 25th, 2025|Endpoints News|
Memo Therapeutics plots Phase 3 trial for kidney infection drug despite mid-stage study missnews2025-07-25T05:00:13+00:00July 25th, 2025|Endpoints News|
How Sarepta’s crisis over patient deaths unfolded, and what happens nextnews2025-07-24T18:13:51+00:00July 24th, 2025|Endpoints News|
Two House lawmakers seek biotech investments to counter Chinanews2025-07-24T17:49:36+00:00July 24th, 2025|Endpoints News|
Vaccine maker Bavarian Nordic confirms it’s in potential takeover talksnews2025-07-24T16:37:26+00:00July 24th, 2025|Endpoints News|
